Novel compounds of the formula (I), in which R, R.sup.1, R.sup.2, R.sup.3
and R.sup.4 have the meaning indicated in Patent Claim 1, are inhibitors
of coagulation factor Xa and can be employed for the prophylaxis and/or
therapy of thromboembolic diseases and for the treatment of tumours.
##STR00001##